Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia

NEXT STORY
Spero Therapeutics Receives FDA Orphan Drug Designation for SPR720 for the Treatment of Nontuberculous Mycobacterial (NTM) Infection
PREV STORY
LexaGene Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

JDRF and Sun Life Financial team up to raise funds for diabetes research

TORONTO, ON--(Marketwired - September 18, 2017) - The JDRF Revolution Ride to Defeat Diabetes, ...

author_avatar
NASDAQ Market News

GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients

author_avatar
NASDAQ Market News

UPDATE: Galecto Hosting Expert Perspective Panel on the Evolving Treatment Landscape for Idiopathic Pulmonary Fibrosis and Potential for GB0139

author_avatar
NASDAQ Market News